Biologics have emerged as the fastest growing segment of pharma development, with biotherapeutics coming to market at an extraordinarily rapid pace. Never before have we seen so many products coming through discovery, development and manufacturing – the timelines are tight, the pressure is on and mistakes are costly.
Your therapeutics have variable molecular complexity and unique analytical needs, and you need to make the best decisions quickly, based on data you can trust.
Make the Shift to High Speed, Complex Biotherapeutics Development SCIEX has a history of pioneering solutions that enable you to succeed in the face of escalating workloads and more complex biotherapeutic characterization demands, where legacy technologies may no longer be up to the task.
Innovation to Speed the Routine and Simplify the Challenging Our biologics characterization solutions now make it possible to extend your analytical capability, increase lab throughput, streamline complex workflows and automate data processing – simplifying complex characterization processes and making them more accessible.
RUO-MKT-18-6005-B For research use only. Not for use in diagnostic procedures.
From intact mass analysis and complex drug-to-antibody ratio determination, to disulfide bond mapping and glycosylation tracking. This compendium offers you the ability to address your challenges in biotherapeutic characterization, highlighting cutting edge techniques for host cell protein quantitation, and explores automated solutions for determining biologics comparability.